99 related articles for article (PubMed ID: 31953835)
1. Genetic Polymorphism of Mismatch Repair Genes and Susceptibility to Prostate Cancer.
Khooshemehri P; Jamaldini SH; Ziaee SAM; Afshari M; Sattari M; Narouie B; Sotoudeh M; Montazeri V; Sarhangi N; Hasanzad M
Urol J; 2020 May; 17(3):271-275. PubMed ID: 31953835
[TBL] [Abstract][Full Text] [Related]
2. Mismatch repair gene MSH3 polymorphism is associated with the risk of sporadic prostate cancer.
Hirata H; Hinoda Y; Kawamoto K; Kikuno N; Suehiro Y; Okayama N; Tanaka Y; Dahiya R
J Urol; 2008 May; 179(5):2020-4. PubMed ID: 18355840
[TBL] [Abstract][Full Text] [Related]
3. The association of four SNPs in DNA mismatch repair genes with idiopathic male infertility in northwest China.
Zhao X; Mu C; Ma J; Dai X; Jiao H
Int J Immunogenet; 2019 Dec; 46(6):451-458. PubMed ID: 31342644
[TBL] [Abstract][Full Text] [Related]
4. Association between genetic polymorphisms in DNA mismatch repair-related genes with risk and prognosis of head and neck squamous cell carcinoma.
Nogueira GA; Lourenço GJ; Oliveira CB; Marson FA; Lopes-Aguiar L; Costa EF; Lima TR; Liutti VT; Leal F; Santos VC; Rinck-Junior JA; Lima CS
Int J Cancer; 2015 Aug; 137(4):810-8. PubMed ID: 25598504
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profile and mutational analysis of DNA mismatch repair genes in carcinoma prostate in Indian population.
Soni A; Bansal A; Singh LC; Mishra AK; Majumdar M; Regina T; Mohanty NK; Saxena S
OMICS; 2011 May; 15(5):319-24. PubMed ID: 21348638
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of MLH1 in benign prostatic hyperplasia and sporadic prostate cancer.
Tanaka Y; Zaman MS; Majid S; Liu J; Kawakami K; Shiina H; Tokizane T; Dahiya AV; Sen S; Nakajima K
Biochem Biophys Res Commun; 2009 Jun; 383(4):440-4. PubMed ID: 19364498
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptors alpha (rs2234693 and rs9340799), and beta (rs4986938 and rs1256049) genes polymorphism in prostate cancer: evidence for association with risk and histopathological tumor characteristics in Iranian men.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Mol Carcinog; 2012 Oct; 51 Suppl 1():E104-17. PubMed ID: 22228197
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers.
Lo YL; Hsiao CF; Jou YS; Chang GC; Tsai YH; Su WC; Chen KY; Chen YM; Huang MS; Hsieh WS; Chen CJ; Hsiung CA
Lung Cancer; 2011 Jun; 72(3):280-6. PubMed ID: 21093954
[TBL] [Abstract][Full Text] [Related]
9. Genetic Polymorphism of MMP2 Gene and Susceptibility to Prostate Cancer.
Adabi Z; Mohsen Ziaei SA; Imani M; Samzadeh M; Narouie B; Jamaldini SH; Afshari M; Safavi M; Roshandel MR; Hasanzad M
Arch Med Res; 2015 Oct; 46(7):546-50. PubMed ID: 26319608
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of comprehensive DNA damage repair gene germline mutations in Chinese prostate cancer patients.
Wu J; Wei Y; Pan J; Jin S; Gu W; Gan H; Zhu Y; Ye DW
Int J Cancer; 2021 Feb; 148(3):673-681. PubMed ID: 33006389
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer.
Wilczak W; Rashed S; Hube-Magg C; Kluth M; Simon R; Büscheck F; Clauditz TS; Grupp K; Minner S; Tsourlakis MC; Möller-Koop C; Graefen M; Adam M; Haese A; Wittmer C; Sauter G; Izbicki JR; Huland H; Schlomm T; Steurer S; Krech T; Lebok P
Carcinogenesis; 2017 Jan; 38(1):19-27. PubMed ID: 27803051
[TBL] [Abstract][Full Text] [Related]
12. High homogeneity of mismatch repair deficiency in advanced prostate cancer.
Fraune C; Simon R; Höflmayer D; Möller K; Dum D; Büscheck F; Hube-Magg C; Makrypidi-Fraune G; Kluth M; Hinsch A; Burandt E; Clauditz TS; Wilczak W; Sauter G; Steurer S
Virchows Arch; 2020 May; 476(5):745-752. PubMed ID: 31811435
[TBL] [Abstract][Full Text] [Related]
13. Reconstitution of
Bowen N; Kolodner RD
Proc Natl Acad Sci U S A; 2017 Apr; 114(14):3607-3612. PubMed ID: 28265089
[TBL] [Abstract][Full Text] [Related]
14. Associations of Genetic Variations in Mismatch Repair Genes MSH3 and PMS1 with Acute Adverse Events and Survival in Patients with Rectal Cancer Receiving Postoperative Chemoradiotherapy.
Yang J; Huang Y; Feng Y; Li H; Feng T; Chen J; Yin L; Wang W; Wang S; Liu Y; Song Y; Li Y; Jin J; Tan W; Lin D
Cancer Res Treat; 2019 Jul; 51(3):1198-1206. PubMed ID: 30590005
[TBL] [Abstract][Full Text] [Related]
15. Association between mismatch repair gene MSH3 codons 1036 and 222 polymorphisms and sporadic prostate cancer in the Iranian population.
Jafary F; Salehi M; Sedghi M; Nouri N; Jafary F; Sadeghi F; Motamedi S; Talebi M
Asian Pac J Cancer Prev; 2012; 13(12):6055-7. PubMed ID: 23464402
[TBL] [Abstract][Full Text] [Related]
16. Mismatch repair polymorphisms and the risk of colorectal cancer.
Berndt SI; Platz EA; Fallin MD; Thuita LW; Hoffman SC; Helzlsouer KJ
Int J Cancer; 2007 Apr; 120(7):1548-54. PubMed ID: 17205513
[TBL] [Abstract][Full Text] [Related]
17. Contribution of the MLH1 -93G>a promoter polymorphism in modulating susceptibility risk in Malaysian colorectal cancer patients.
Nizam ZM; Abdul Aziz AA; Kaur G; Abu Hassan MR; Mohd Sidek AS; Yeh LY; Mazuwin M; Ankathil R
Asian Pac J Cancer Prev; 2013; 14(2):619-24. PubMed ID: 23621208
[TBL] [Abstract][Full Text] [Related]
18. Loss of DNA mismatch repair proteins in prostate cancer.
Sharma M; Yang Z; Miyamoto H
Medicine (Baltimore); 2020 May; 99(19):e20124. PubMed ID: 32384491
[TBL] [Abstract][Full Text] [Related]
19. MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer.
Raptis S; Mrkonjic M; Green RC; Pethe VV; Monga N; Chan YM; Daftary D; Dicks E; Younghusband BH; Parfrey PS; Gallinger SS; McLaughlin JR; Knight JA; Bapat B
J Natl Cancer Inst; 2007 Mar; 99(6):463-74. PubMed ID: 17374836
[TBL] [Abstract][Full Text] [Related]
20. DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells.
Fukuhara S; Chang I; Mitsui Y; Chiyomaru T; Yamamura S; Majid S; Saini S; Hirata H; Deng G; Gill A; Wong DK; Shiina H; Nonomura N; Dahiya R; Tanaka Y
Oncotarget; 2014 Nov; 5(22):11297-307. PubMed ID: 25526032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
